Skip to content
healthcare.dev

UTI INFECTION CONTROL

NDC 73436-1221, Methenamine, Sodium Salicylate, tablet, from CADENCE HEALTH, INC..

Product NDC
73436-1221
Status
Listed
Labeler
CADENCE HEALTH, INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73436-1221 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHENAMINE162 mg/1
  • SODIUM SALICYLATE162.5 mg/1
Package NDCNDC-11Package
73436-1221-2734361221021 BLISTER PACK in 1 CARTON (73436-1221-2) / 12 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73436-1221 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73436-1221 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73436-1221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.